Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment — a systematic review ; volume:181 ; number:4 ; day:22 ; month:12 ; year:2021 ; pages:1329-1362 ; date:4.2022
Zeitschrift für Kinderheilkunde ; 181, Heft 4 (22.12.2021), 1329-1362, 4.2022
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00431-021-04283-w
- URN
-
urn:nbn:de:101:1-2022061810101997768786
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Keller, Michèle
- Pittet, Laure
- Zimmermann, Petra
- SpringerLink (Online service)
Other Objects (12)
Exploring the relationship between nutritional status and immunogenicity of routine childhood vaccines
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Immunogenicity of poxvirus-based vaccines against Nipah virus
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Exploring the relationship between nutritional status and immunogenicity of routine childhood vaccines
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Immunogenicity of poxvirus-based vaccines against Nipah virus
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Exploring the relationship between nutritional status and immunogenicity of routine childhood vaccines
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Immunogenicity of poxvirus-based vaccines against Nipah virus
Improving the immunogenicity of HIV-1 envelope trimer vaccines
Factors affecting the immunogenicity of influenza vaccines in human
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases
Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines